Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hakim Lakhani"'
Autor:
Amy Gallant, Teresa J. Mazeika, Audrea Szabatura, Alan H. Breaud, Hakim Lakhani, Garrett Rompelman, Khanh Tu Do, Anna Shanedling, Laura Cedro, Caryn M Caparrotta, Sylvia Bartel
Publikováno v:
Journal of Clinical Oncology. 37:257-257
257 Background: At Dana-Farber Cancer Institute (DFCI), timing of order release to the pharmacy is a contributing factor to safety and processing concerns for oral investigational medications. Day-of release can lead to delayed delivery to the patien
A proactive approach to assess system safety in clinical operations at a comprehensive cancer center
Autor:
Sarah Kadish, Sylvia Bartel, Lawrence Wong, Laura Cedro, Shannon L. Rowell, Caroline Harvey, Alan H. Breaud, Hakim Lakhani, David John Frank, Audrea Szabatura, Jeffrey Durney, Sharon Lane
Publikováno v:
Journal of Clinical Oncology. 37:245-245
245 Background: Traditional approaches to improve safety in clinical operations focus on reacting to adverse events and intervening at the process level to prevent recurrence. A need exists to proactively explore safety at the system level and evalua
Publikováno v:
Journal of Clinical Oncology. 36:296-296
296 Background: Quantifying the performance of a cancer center’s cancer registry is important to plan for resources needed to address shortcomings and projected increases in workload. The objective of this project was to understand the workflow, re
Autor:
Sylvia Bartel, Andrew J. Wagner, Barbara Fine, Michael D Kearney, Mark Pettengill, Shital Shukla, Michael S. Rabin, Rachel A Wolfberg, Jing Jing Wang Yakowec, Hakim Lakhani, Ursula A. Matulonis, Nancy Hilton
Publikováno v:
Journal of Clinical Oncology. 36:123-123
123 Background: Many factors contribute to long wait times for oncology patients on the day of their infusion appointment. At Dana-Farber Cancer Institute (DFCI), one of the main causes of delay to infusion start is providers not signing medication o
Publikováno v:
Journal of Clinical Oncology. 36:4-4
4 Background: Evidence has shown that long infusion wait time is one of the main contributors to oncology patient dissatisfaction. To identify bottlenecks and inefficient processing, a comprehensive understanding of the infusion workflow at Dana-Farb
Autor:
Sylvia Bartel, Andrew J. Wagner, Hakim Lakhani, Jing Jing Wang Yakowec, Barbara Fine, Michael D Kearney, Nancy Hilton, Michael S. Rabin, Shital Shukla, Ursula A. Matulonis, Mark Sudol, Rachel A Wolfberg
Publikováno v:
Journal of Clinical Oncology. 36:129-129
129 Background: Many factors contribute to long wait times for cancer patients on the day of their infusion. At Dana-Farber Cancer Institute (DFCI), a contributing factor is patient flow between exam and infusion. Order verification affects patient f